Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India
- PMID: 34366135
- PMCID: PMC8233962
- DOI: 10.1016/j.mayocp.2021.06.003
Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India
Comment in
-
Lessons From India's Second Wave: Real World Effectiveness of Health Care Worker Vaccination.Mayo Clin Proc. 2021 Sep;96(9):2301-2302. doi: 10.1016/j.mayocp.2021.07.012. Mayo Clin Proc. 2021. PMID: 34481594 Free PMC article. No abstract available.
Similar articles
-
Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles.Ann Intern Med. 2021 Jun;174(6):882-885. doi: 10.7326/M20-7580. Epub 2021 Feb 9. Ann Intern Med. 2021. PMID: 33556267 Free PMC article. No abstract available.
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
-
Revisiting regulatory framework in India for accelerated vaccine development in pandemics with an evidence-based fast-tracking strategy.Indian J Med Res. 2020 Jul & Aug;152(1 & 2):156-163. doi: 10.4103/ijmr.IJMR_3640_20. Indian J Med Res. 2020. PMID: 32952146 Free PMC article. No abstract available.
-
International COVID-19 vaccine inequality amid the pandemic: Perpetuating a global crisis?J Glob Health. 2021 Jul 3;11:03086. doi: 10.7189/jogh.11.03086. J Glob Health. 2021. PMID: 34221356 Free PMC article. Review. No abstract available.
-
What Are COVID-19 Vaccines?Am J Respir Crit Care Med. 2021 May 1;203(9):P22-P23. doi: 10.1164/rccm.2021C2. Am J Respir Crit Care Med. 2021. PMID: 33759735 No abstract available.
Cited by
-
Effectiveness of a monitored home isolation program for COVID-19 infection during the second wave of the pandemic.Med J Armed Forces India. 2022 Sep 2;80(3):327-34. doi: 10.1016/j.mjafi.2022.06.022. Online ahead of print. Med J Armed Forces India. 2022. PMID: 36068859 Free PMC article.
-
Clinical profile of ChAdOx1 nCoV-19- and BBV152-vaccinated individuals among hospitalized COVID-19 patients: a pair-matched study.Ther Adv Vaccines Immunother. 2022 Aug 9;10:25151355221115009. doi: 10.1177/25151355221115009. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35966176 Free PMC article.
-
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.EClinicalMedicine. 2021 Dec;42:101218. doi: 10.1016/j.eclinm.2021.101218. Epub 2021 Nov 30. EClinicalMedicine. 2021. PMID: 34870133 Free PMC article.
-
Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (CovishieldTM) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021.Vaccines (Basel). 2022 Jun 17;10(6):970. doi: 10.3390/vaccines10060970. Vaccines (Basel). 2022. PMID: 35746578 Free PMC article.
-
Determinants of COVID-19 Breakthrough Infections and Severity in ChAdOx1 nCoV-19-Vaccinated Priority Groups.Am J Trop Med Hyg. 2022 Aug 8;107(4):850-855. doi: 10.4269/ajtmh.22-0172. Print 2022 Oct 12. Am J Trop Med Hyg. 2022. PMID: 35940202 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical